Prescription
Pharmaceuticals

At ROVI, we have a diversified portfolio comprising around thirty of our own and licensed products.
Our portfolio has a defensive profile, since it has been practically unaffected by reference pricing
in Spain and no significant patents will expire until 2019.

Ameride

Ameride®

Active Substance
Amiloride hydrochloride and hydrochlorothiazide

Therapeutic Area
Cardiovascular

License
ROVI propietary product

Bertanel

Bertanel®

Active Substance
Methotrexate

Therapeutic Area
Osteoarticular

License
License from Ebewe Pharma Gmbh Nfg. KG

Bluxam

BLUXAM

Active Substance
Hexacetonido de triamcinolona.

Therapeutic Area
Osteoarticular

License
License from Riemser Pharma Gmbh

Enoxaparin

ENOXAPARIN ROVI®

Active Substance
Sodium enoxaparin

Therapeutic Area
Thrombosis

License
ROVI propietary product

Calcium and vitamine D3 ROVI

CALCIUM AND VITAMINE
D3 ROVI®

Active Substance
Calcium carbonate and cholecalciferol concentrate.

Therapeutic Area
Osteoarticular

License
ROVI propietary product

Exxiv

EXXIV®

Active Substance
Etoricoxib

Therapeutic Area
Osteoarticular and pain release

License
License from MSD

Prinivil

Prinivil®

Active Substance
Lisinopril

Therapeutic Area
Cardiovascular

License
ROVI propietary product

Rhodogil

Rhodogil®

Active Substance
Spiramycin and Metronidazole

Therapeutic Area
Antibacterial

License
ROVI propietary product

Glufan

GLUFAN®

Active Substance
Glucosamine hydrochloride

Therapeutic Area
Osteoarticular

License
ROVI propietary product

Hibor

Hibor®

Active Substance
Sodium bemiparin

Therapeutic Area
Thrombosis

License
ROVI propietary product

Hirobriz

Hirobriz®
Breezhaler®

Active Substance
Indacaterol maleate

Therapeutic Area
Pneumology

License
License from Novartis Europharm Limited

Neparvis

NEPARVIS®

Active Substance
Sacubitril/valsartan

Therapeutic Area
Cardiovascular

License
License from Novartis Europharm Limited

Medicebran

Medicebran®

Active Substance
Methylphenidate hydrochloride with inmediate release

Therapeutic Area
Central nervous system

License
License from MEDICE

Access to the physician´s guide and supportive material for monitoring of therapy through this link

Medikinet

Medikinet®

Active Substance
Methyilphenidate hydrochloride with modified release

Therapeutic Area
Central nervous system

License
License from MEDICE

Access to the physician´s guide and supportive material for monitoring of therapy through this link

Mysimba

Mysimba®

Active Substance
Naltrexone hydrochloride and bupropion hydrochloride. Prolonged release.

Therapeutic Area
Endocrinology

License
License from OREXIGEN

Orvatez

Orvatez®

Active Substance
Ezetimibe and Atorvastatin

Therapeutic Area
Cardiovascular

License
License from MSD

Tryptizol

Tryptizol®

Active Substance
Amitriptyline hydrochloride

Therapeutic Area
Central nervous system

License
ROVI propietary product

Ulunar Breezhaler

Ulunar®
Breezhaler®

Active Substance
Indacaterol maleate and
glycopyrronium bromide

Therapeutic Area
Pneumology

License
License from Novartis Europharm Limited

Volutsa

Volutsa®

Active Substance
Solifenacin succinate and tamsulosin hydrochloride

Therapeutic Area
Urology

License
License from Astellas Pharma